There were 783 press releases posted in the last 24 hours and 164,643 in the last 365 days.

Implantable Cardioverter Defibrillator Market to reach US$ 8,343.4 Mn by 2026, Medtronic Leads the Market with Increasing Customer Reach, says Fortune Business Insights

Key companies covered in the Implantable Cardioverter Defibrillator Market Research report include LivaNova PLC, Medtronic, Abbott, BIOTRONIK, Boston Scientific Corporation, and MicroPort. among others.

/EIN News/ -- Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global Implantable Cardioverter Defibrillator Market or ICD market is anticipated to expand at a reasonable growth rate in the coming years. The rising prevalence of cardiovascular disorders is the chief factor responsible for this growth. This information was published in a report, titled Implantable Cardioverter Defibrillator ICD Market: Global Market Analysis, Insights and Forecast, 2018-2026” which offers insights into the factors enabling growth in the market. According to the report, the global market was valued at US$ 6684.4 Mn in the year 2017 an is estimated to reach US$ 8343.4 Mn by 2026.


Browse Complete Report Details with Table of Content and Figures:
https://www.fortunebusinessinsights.com/industry-reports/implantable-cardioverter-defibrillator-market-100474


Hospitals to Witness High Adoption of ICDs in the coming years

The availability of implantable defibrillators is expected to grow in hospitals more than among other end-users. In the coming years, hospitals are likely to be well-equipped with ICD devices and automated ICDs. Furthermore, governments may introduce several policies to support the adoption of ICD devices in hospitals. Different types of ICD products such as subcutaneous ICD and transvenous ICD are introduced in the report. Subcutaneous ICDs are expected to grow at a faster rate than transvenous ICDs. This is primarily on account of their large size and greater battery capacity. Moreover, Boston Scientific Corporation had launched the first subcutaneous ICD in the world in 2012. In 2018, transvenous ICD covered a significant share, but presently subcutaneous leads the ICD market.  

Europe to Remain Dominant by Covering the Highest Share

Among regions, Europe is expected to lead the global ICD market in the forecast years owing to rising adoption of ICD devices. The growing prevalence of cardiac diseases is resulting in high adoption of these devices. Moreover, the region generated a value of US$ 3376.8 Mn in the year 2018 and continues to generate higher growth until 2026. In addition to this, rising awareness about advantages of ICD devices is likely to create growth opportunities for the market in this region. Introduction of favorable reimbursement guidelines by governments in Europe stimulates growth in the market. Besides Europe, North America is also expected to grow at a significant rate and become the second most leading region.  

Rising Adoption of ICDs Intended to Save Life of Patients from Sudden Cardiac Arrests

“The prevalence of cardiac arrhythmias is rising across the world as more people are opting to live with sedentary lifestyle,” observes a lead analyst at Fortune Business Insights. “ICD manufacturers are planning to develop ICD devices and save the quality life of such patients,” he adds. Fortune Business Insights predicts the demand for ICDs to increase as these devices can regulate irregular heartbeats of patients suffering from cardiac disorders. Another factor responsible for driving the ICD market is the rising cases of cardiovascular diseases in developing and developed regions. Further to this, the demand for ICDs or automated implantable ventilator defibrillators is increasing in regions such as Asia Pacific owing to the rising prevalence of cardiac arrests. The awareness about cardiac-related diseases in countries such as Brazil, India, and China is increasing, which is further expected to boost the market. Governments are conducting awareness and training programs for patients to encourage growth of ICD devices.


Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/implantable-cardioverter-defibrillator-market-100474


Medtronic and Boston Scientific Corporation to Cover Majority of the Share in the Market 

The global ICD market covers some of the leading players which include LivaNova PLC, Medtronic, Abbott, BIOTRONIK, Boston Scientific Corporation, and MicroPort. Among these, Medtronic leads the market by covering majority of the share as per revenue. The company over the years has gained customers and built its brand recognition. Medtronic and Boston Scientific Corporation accounts for than more than half of the share in terms of revenue in the global market. Several companies are focusing on product launches to strengthen their global reach. For instance, Biotronik announced the launch of Acticor series in April 2019. These series consist of newly developed implantable defibrillator devices. Also, these devices help to reduce cost, time, and have less number of leads. Another company called Boiotronik launched defibrillators with ulta-high energy in December 2016. This launch was done in the U.S. market for the effective treatment of heart failure.

Key companies covered in the report

  • Medtronic
  • Boston Scientific Corporation
  • Biotronik
  • LivaNova Plc
  • Abbott
  • Microport
  • Other prominent players


Speak to Analyst  https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/implantable-cardioverter-defibrillator-market-100474


Table of Content:

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    •  Market Opportunities

  • Key Insights
    • Prevalence of Sudden Cardiac Arrest- Key Countries
    • Technological Developments in Implantable Defibrillators
    • Key Mergers and Acquisitions

  • Global Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast,2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product Type
      • Transveneous ICD
        • Single Chamber ICD
        • Dual Chamber ICD
        • CRT-D (Cardiac Resynchronization Therapy- Defibrillator)
      • Subcutaneous ICD

    • Market Analysis, Insights and Forecast – By End User
      • Clinics and Hospitals
      • Ambulatory Surgery Centers and Others

    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of the World
  • Competitive Analysis
  • Strategic Recommendations


Request for Customization:    https://www.fortunebusinessinsights.com/enquiry/customization/implantable-cardioverter-defibrillator-market-100474


Browse Related Reports:

  • Defibrillators Market Size, Share and Global Trend by Type (Implantable Cardioverter Defibrillator (ICD), Transvenous ICD, External Defibrillator) By End User (Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Geography Forecast till 2026

  • External Defibrillator Market Size, Share and Global Trend by Product (Automated External Defibrillator (AED), Manual and Semi-Automatic External Defibrillator, Wearable External Defibrillator), By End User (Hospitals & Clinics, Schools and other Public Places) and Geography Forecast till 2026

  • Cardiac Rhythm Management Devices Market Size, Share and Global Trend Product by (Cardiac Pacemakers, Defibrillators, Cardiac Resynchronization Therapy Devices) By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Geography Forecast to 2026

  • Cardiac Pacemakers Market Size, Share and Global Trend by Product (Single Chamber Pacemakers, Dual Chamber Pacemakers, Cardiac Resynchronization Therapy-Pacemakers (CRT-P)), By End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Geography Forecast till 2026


About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact us:
Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com 
Website: https://www.fortunebusinessinsights.com

Attachment

Primary Logo

Medtronic and Boston Scientific Corporation to Account for More Than Half of the Market Share in Terms of Revenue

Implantable Cardioverter Defibrillator Market Size, Share and Global Trends


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.